C20orf181: A Drug Target / Disease Biomarker (G100128998)

Target Name: C20orf181

NCBI ID: G100128998

C20orf181

Other Name(s): Chromosome 20 open reading frame 181 | chromosome 20 putative open reading frame 181 | dJ824A14.1

C20orf181: A Drug Target / Disease Biomarker

C20orf181 is a protein that is expressed in various tissues throughout the body. It is a part of the C20orf1 gene family, which has been implicated in the development and progression of a variety of diseases, including cancer. Researchers have been investigating the potential drug targets of C20orf181 for the treatment of various diseases, including cancer, and have made significant progress in understanding its role in these processes.

One of the main goals of research into C20orf181 is to identify its functions and to understand its role in the development and progression of diseases. This is an important step in the development of new drugs, as understanding the underlying mechanisms of a protein can help scientists to identify potential targets that are more likely to be effective.

One of the key functions of C20orf181 is its role in the regulation of cell growth and division. This is an important process that is essential for the growth and development of all cells, and it is also involved in the regulation of cancer cell growth. C20orf181 has been shown to play a key role in regulating cell growth and division by controlling the activity of several key signaling pathways.

Another important function of C20orf181 is its role in the regulation of gene expression. This is a complex process that is essential for the development and progression of diseases, and it is also involved in the regulation of cancer cell growth. C20orf181 has been shown to play a key role in regulating gene expression by controlling the activity of several key signaling pathways.

In addition to its role in cell growth and division, C20orf181 is also involved in the regulation of several other important processes that are involved in the development and progression of diseases. This includes its role in the regulation of cell adhesion, the development of blood vessels, and the regulation of inflammation.

Overall, C20orf181 is a protein that is involved in a wide range of important processes that are involved in the development and progression of diseases. As such, it has significant potential as a drug target, and research into its functions and its role in these processes is an important area of research that could lead to the development of new treatments for a variety of diseases.

Protein Name: Chromosome 20 Putative Open Reading Frame 181

The "C20orf181 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C20orf181 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets